This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Metrogel (Metronidazole Topical) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (7)
Reports by Reaction Type
Diverticulitis (2),
Abasia (1),
Skin Burning Sensation (1),
Headache (1),
Dermatitis (1),
Back Pain (1),
Nausea (1),
Pain in Extremity (1),
Drug Hypersensitivity (1),
Musculoskeletal Pain (1),
Breast Cancer Female (1),
Skin Irritation (1)
Possible Metrogel side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-19
Patient: female
Reactions: Drug Hypersensitivity
Drug(s) suspected as cause:
Lotrimin
Tigan
Metrogel
Morphine Sulfate
Amoxicillin
Ceftin
Ciprofloxacin Hydrochloride
Potassium Pencillin G
Macrodantin
Sulfamethoxazole
Possible Metrogel side effects in female
Reported by a individual with unspecified qualification from United States on 2012-02-02
Patient: female
Reactions: Breast Cancer Female
Drug(s) suspected as cause:
Metrogel
Possible Metrogel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-04
Patient: female, weighing 97.0 kg (213.4 pounds)
Reactions: Diverticulitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Oracea
Dosage: (40 mg qd oral)
Administration route: Oral
Indication: Rosacea
Start date: 2011-11-18
End date: 2011-12-04
Metrogel
Dosage: (1 df qd topical)
Administration route: Topical
Indication: Rosacea
Start date: 2011-11-18
End date: 2011-12-04
Other drugs received by patient: Celexa; Orlistat; Calcium; Ascorbic Acid; Coelcalciferol
Possible Metrogel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-27
Patient: female, weighing 97.0 kg (213.4 pounds)
Reactions: Diverticulitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Oracea
Dosage: (40 mg qd oral)
Administration route: Oral
Indication: Rosacea
Start date: 2011-11-18
End date: 2011-12-05
Metrogel
Dosage: (1 df qd topical)
Administration route: Topical
Indication: Rosacea
Start date: 2011-11-18
End date: 2011-12-05
Other drugs received by patient: Colecalciferol; Ascorbic Acid; Orlistat; Celexa; Calcium Acetate
Possible Metrogel side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-27
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Back Pain, Pain in Extremity, Abasia, Musculoskeletal Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxycycline
Dosage: (40 mg qd oral) (40 mgqd oral)
Administration route: Oral
Indication: Rosacea
Start date: 2011-11-22
End date: 2011-11-30
Doxycycline
Dosage: (40 mg qd oral) (40 mgqd oral)
Administration route: Oral
Indication: Rosacea
Start date: 2011-11-17
End date: 2011-11-21
Metrogel
Dosage: (1 df qd topical)
Administration route: Topical
Indication: Rosacea
Start date: 2011-11-17
End date: 2011-11-30
Other drugs received by patient: Ascorbic Acid; Vytorin; Calcium Citrate; Nitroglycerin; Multivitamin / 05992801 /; Aspirin; Curcuma Longa; Altace; Colecalciferol; Plavix; Lovaza; Magnesium; Tocopherol Concentrate CAP; MSM; SAW Palmetto
Possible Metrogel side effects in 43 year old female
Reported by a consumer/non-health professional from United States on 2011-12-13
Patient: 43 year old female
Reactions: Dermatitis, Rosacea, Skin Burning Sensation, Skin Irritation
Drug(s) suspected as cause:
Doxycycline
Administration route: Oral
Indication: Rosacea
Start date: 2011-04-01
End date: 2011-04-14
Metrogel
Administration route: Topical
Indication: Rosacea
Start date: 2011-04-01
End date: 2011-04-02
Possible Metrogel side effects in 44 year old female
Reported by a consumer/non-health professional from United States on 2011-10-25
Patient: 44 year old female, weighing 59.0 kg (129.7 pounds)
Reactions: Nausea, Headache
Drug(s) suspected as cause:
Metrogel
|
